CDK4
Cyclin-dependent kinase 4
Also known as: CDK4_HUMAN, PSK-J3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11802
- Gene
- CDK4
- Ensembl
- ENSG00000135446
- Chromosome
- 12
- Canonical length
- 303 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
303 residues, UniProt reviewed canonical sequence.
>P11802|CDK4
1 MATSRYEPVA EIGVGAYGTV YKARDPHSGH FVALKSVRVP NGGGGGGGLP ISTVREVALL
61 RRLEAFEHPN VVRLMDVCAT SRTDREIKVT LVFEHVDQDL RTYLDKAPPP GLPAETIKDL
121 MRQFLRGLDF LHANCIVHRD LKPENILVTS GGTVKLADFG LARIYSYQMA LTPVVVTLWY
181 RAPEVLLQST YATPVDMWSV GCIFAEMFRR KPLFCGNSEA DQLGKIFDLI GLPPEDDWPR
241 DVSLPRGAFP PRGPRPVQSV VPEMEESGAQ LLLEMLTFNP HKRISAFRAL QHSYLHKDEG
301 NPELocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDK4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 115 nTPM
Expression across tissuesHPA
Tissue
- ovary: 115 nTPM
- endometrium: 92 nTPM
- adrenal gland: 88 nTPM
- cervix: 83 nTPM
- smooth muscle: 75 nTPM
- pancreas: 73 nTPM
Single-cell type
- hofbauer cells: 197 nCPM
- decidual stromal cells: 195 nCPM
- esophageal basal cells: 181 nCPM
- migrating cytotrophoblasts: 147 nCPM
- erythrocyte progenitors: 145 nCPM
- extravillous trophoblasts: 144 nCPM
Immune cell
- memory B-cell: 94 nTPM
- naive CD4 T-cell: 93 nTPM
- naive B-cell: 90 nTPM
- plasmacytoid DC: 85 nTPM
- naive CD8 T-cell: 85 nTPM
- MAIT T-cell: 82 nTPM
Brain region
- basal ganglia: 29 nTPM
- cerebellum: 29 nTPM
- spinal cord: 29 nTPM
- thalamus: 29 nTPM
- hypothalamus: 28 nTPM
- medulla oblongata: 28 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CDK4.
Disease | AllUniProt
Conditions CDK4 is implicated in, by any mechanism.
- Melanoma, cutaneous malignant 3 (CMM3) MIM:609048
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 1,313 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Melanoma, cutaneous malignant, susceptibility to, 3
- Familial melanoma
- Hereditary cancer-predisposing syndrome
- Gastric cancer
Disease | ImmuneIEDB
Conditions an epitope on CDK4 was assayed in.
- myeloid leukemia T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 1.49
- DepMap mean gene effect
- -0.76
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- cellular response to interleukin-4
- cellular response to ionomycin
- cellular response to lipopolysaccharide
- cellular response to phorbol 13-acetate 12-myristate
- G1/S transition of mitotic cell cycle
- positive regulation of cell population proliferation
- positive regulation of fibroblast proliferation
- positive regulation of G2/M transition of mitotic cell cycle
- regulation of cell cycle
- regulation of G2/M transition of mitotic cell cycle
- regulation of gene expression
- regulation of transcription initiation by RNA polymerase II
- regulation of type B pancreatic cell proliferation
- response to xenobiotic stimulus
- signal transduction
Molecular functions
- ATP binding
- cyclin binding
- cyclin-dependent protein serine/threonine kinase activity
- cyclin-dependent protein serine/threonine kinase regulator activity
- protein serine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDK4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDK4 as an antibody target. Whether an autoantibody or antibody against CDK4 could matter depends on whether native CDK4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDK4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDK4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...